When Shkreli speaks bluntly about the needs of shareholders, without the buzzwords and public relations scripts, he makes big pharma very uncomfortable.
Because he's telling the truth.
Read Full Article »When Shkreli speaks bluntly about the needs of shareholders, without the buzzwords and public relations scripts, he makes big pharma very uncomfortable.
Because he's telling the truth.
Read Full Article »